| NOVARTIS NAM. SF 0,50 |
| ISIN | CH0012005267 |
| Security | NOVN |
| Exchange | EUREX |
| Type | Option |
Options
| Exp. date | Type | Type |
|---|---|---|
| 11/19 | 31 Calls | 30 Puts |
| 12/19 | 67 Calls | 66 Puts |
| 1/20 | 29 Calls | 29 Puts |
| 3/20 | 31 Calls | 30 Puts |
| 6/20 | 40 Calls | 40 Puts |
| 9/20 | 10 Calls | 10 Puts |
| 12/20 | 40 Calls | 40 Puts |
| 6/21 | 22 Calls | 22 Puts |
| 12/21 | 22 Calls | 22 Puts |
| 6/22 | 8 Calls | 8 Puts |
| 12/22 | 19 Calls | 19 Puts |
| 12/23 | 18 Calls | 18 Puts |
News
- Precision BioSciences Welcomes Healthcare Industry Expert, Kevin J. Buehler, to its Board of Directors
13:00 - GlobeNewswire - Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update
11/12/2019 / 22:28 - GlobeNewswire - Homology Medicines Reports Third Quarter 2019 Financial Results and Recent Highlights
11/12/2019 / 22:09 - GlobeNewswire - HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update
11/12/2019 / 22:01 - GlobeNewswire - Novartis' net sales up 10% to $12.17B in Q3
10/22/2019 / 07:03 - TeleTrader
Real-time